Cephalon completes acquisition of Arana for $207 million

08/10/2009 | American City Business Journals

Arana Therapeutics will operate as Cephalon's wholly owned unit after Cephalon finalized the acquisition of the Australian biotech firm for $207 million. Cephalon Chairman and CEO Frank Baldino expects the acquisition to bring the company into biologics through Arana's biotech drug candidates for inflammatory diseases and solid tumors.

View Full Article in:

American City Business Journals

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Manager/Senior Manager, Health Services Analytics
Avalere Health
Washington, DC
Manager/Senior Manager, Health Economist
Avalere Health
Washington, DC
Director, Health Services Analytics
Avalere Health
Washington, DC
Director/Vice President. Health Actuary
Avalere Health
Washington, DC
Attorney
U.S. DEPARTMENT OF HEALTH & HUMAN SERVICES Food and Drug Administration Office of the Chief Counsel
Silver Spring, MD, MD